Science Explorer Back to mapMap
Discussion
Researcher · Cyclacel Pharmaceuticals (United Kingdom) · United Kingdom

Judy H. Chiao

Judy H. Chiao publishes mostly in Oncology, Hematology and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Advanced Breast Cancer Therapies and Histone Deacetylase Inhibitors Research.

ORCID 0000-0002-2818-4644 OpenAlex
World rank
#708,255
of 7,710,434 ranked researchers
Rank in United Kingdom
#59,606
of 367,258
Works
50
Citations
4.3k
Citations per work
85.6
h-index
18
i10-index 22Top 28% in Oncology
Judy H. Chiao

What does Judy H. Chiao research?

Judy H. Chiao's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (15%).

Health Sciences: 30 works · 60.7% of their workMedicine: 30 works · 60.7% of their workOncology: 11 works · 21.4% of their workHematology: 8 works · 15.9% of their workPulmonary and Respiratory Medicine: 5 works · 10.3% of their workGenetics: 3 works · 6.9% of their workPublic Health, Environmental and Occupational Health: 3 works · 6.2% of their workEverything else: 12 works · 24.1% of their workLife Sciences: 8 works · 15.2% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 15.2% of their workMolecular Biology: 8 works · 15.2% of their workTHEIR WORKJudy H. Chiao50works
Life Sciences15%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3060.7%
  2. Everything else1224.1%
    1. Biochemistry, Genetics and Molecular Biology815.2%
  1. 1Oncology21% of their works
  2. 2Hematology16% of their works
  3. 3Molecular Biology15% of their works
  4. 4Pulmonary and Respiratory Medicine10% of their works
  5. 5Genetics7% of their works
  6. 6Public Health, Environmental and Occupational Health6% of their works

Research topics

Which keywords describe Judy H. Chiao's research?

The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Cancer Therapy, Breast Cancer, CDK4/6 Inhibitors, Acute Lymphoblastic Leukemia and Antiretroviral Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors353 topics
  2. AML171 topic
  3. Acute Myeloid Leukemia171 topic
  4. Cancer Therapy162 topics
  5. Breast Cancer141 topic
  6. CDK4/6 Inhibitors141 topic
  7. Acute Lymphoblastic Leukemia91 topic
  8. Antiretroviral Therapy91 topic
  9. Childhood Cancer91 topic
  10. Chronic Lymphocytic Leukemia91 topic
  11. Genomic Aberrations91 topic
  12. HDAC Inhibitors91 topic
  13. HIV Infection91 topic
  14. Histone Deacetylases91 topic
  15. Cell Cycle71 topic
  16. p5371 topic
  17. Folate51 topic
  18. Homocysteine51 topic

Where does Judy H. Chiao work?

Judy H. Chiao's main affiliation in the publication record is Cyclacel Pharmaceuticals (United Kingdom), United Kingdom.

How many publications and citations does Judy H. Chiao have?

OpenAlex counts 50 works and 4,281 citations for Judy H. Chiao, an h-index of 18, ranking #708,255 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Judy H. Chiao. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.